These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 31486577)

  • 1. Pheochromocytoma: Positive predictive values of mildly elevated urinary fractionated metanephrines in a large cohort of community-dwelling patients.
    Hirsch D; Grossman A; Nadler V; Alboim S; Tsvetov G
    J Clin Hypertens (Greenwich); 2019 Oct; 21(10):1527-1533. PubMed ID: 31486577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary Free Metanephrines for Diagnosis of Pheochromocytoma and Paraganglioma.
    Ahn J; Park JY; Kim G; Jin SM; Hur KY; Lee SY; Kim JH
    Endocrinol Metab (Seoul); 2021 Jun; 36(3):697-701. PubMed ID: 34107605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Properly Collected Plasma Metanephrines Excludes PPGL After False-Positive Screening Tests.
    Kline GA; Boyd J; Polzin B; Harvey A; Pasieka JL; Sadrzadeh HSM; Leung AA
    J Clin Endocrinol Metab; 2021 Jul; 106(8):e2900-e2906. PubMed ID: 33846745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The challenge of improving the diagnostic yield from metanephrine testing in suspected phaeochromocytoma and paraganglioma.
    Samsudin I; Page MM; Hoad K; Chubb P; Gillett M; Glendenning P; Vasikaran S
    Ann Clin Biochem; 2018 Nov; 55(6):679-684. PubMed ID: 29660998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical factors affecting spot urine fractionated metanephrines in patients suspected pheochromocytoma/paraganglioma.
    Bokuda K; Yatabe M; Seki Y; Ichihara A
    Hypertens Res; 2020 Jun; 43(6):543-549. PubMed ID: 32020083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for phaeochromocytoma and paraganglioma: impact of using supine reference intervals for plasma metanephrines with samples collected from fasted/seated patients.
    Casey R; Griffin TP; Wall D; Dennedy MC; Bell M; O'Shea PM
    Ann Clin Biochem; 2017 Jan; 54(1):170-173. PubMed ID: 27166307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different diagnostic cut-off values of urinary fractionated metanephrines according to sex for the diagnosis of pheochromocytoma in Korean subjects.
    Sohn SY; Park HD; Lee SY; Kim JH; Jung BC; Kim HJ; Jang HW; Kim KW; Lee MK; Min YK; Kim JH
    Endocr J; 2012; 59(9):831-8. PubMed ID: 22785075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of plasma metanephrines measured by a commercial immunoassay and urinary catecholamines in the diagnosis of pheochromocytoma.
    Christensen TT; Frystyk J; Poulsen PL
    Scand J Clin Lab Invest; 2011 Dec; 71(8):695-700. PubMed ID: 22023043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of endocrine disease: Biochemical diagnosis of phaeochromocytoma and paraganglioma.
    van Berkel A; Lenders JW; Timmers HJ
    Eur J Endocrinol; 2014 Mar; 170(3):R109-19. PubMed ID: 24347425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary clonidine suppression testing for the diagnosis of pheochromocytoma.
    Goupil R; Fountoulakis S; Gordon RD; Stowasser M
    J Hypertens; 2015 Nov; 33(11):2286-93. PubMed ID: 26335433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonidine suppression test for a reliable diagnosis of pheochromocytoma: When to use.
    Tsiomidou S; Pamporaki C; Geroula A; Van Baal L; Weber F; Dralle H; Schmid KW; Führer D; Unger N
    Clin Endocrinol (Oxf); 2022 Nov; 97(5):541-550. PubMed ID: 35274752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines.
    Sawka AM; Jaeschke R; Singh RJ; Young WF
    J Clin Endocrinol Metab; 2003 Feb; 88(2):553-8. PubMed ID: 12574179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of plasma free metanephrines in diagnosis of pheochromocytomas and paragangliomas in the population of Asturias.
    Martínez-Morillo E; Valdés Gallego N; Eguia Ángeles E; Fernández Fernández JC; Prieto García B; Álvarez FV
    Endocrinol Diabetes Nutr (Engl Ed); 2019 May; 66(5):312-319. PubMed ID: 30391255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-centre study of the diagnostic performance of plasma metanephrines with seated sampling for the diagnosis of phaeochromocytoma/paraganglioma.
    Boot C; Toole B; Johnson SJ; Ball S; Neely D
    Ann Clin Biochem; 2017 Jan; 54(1):143-148. PubMed ID: 27170024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Verifying Clinically Derived Reference Intervals for Daily Excretion Rates of Fractionated Metanephrines Using Modern Indirect Reference Interval Models.
    Doyle K; Frank EL
    Am J Clin Pathol; 2021 Sep; 156(4):691-699. PubMed ID: 33880513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnostic efficacy of urinary fractionated metanephrines measured by tandem mass spectrometry in detection of pheochromocytoma.
    Perry CG; Sawka AM; Singh R; Thabane L; Bajnarek J; Young WF
    Clin Endocrinol (Oxf); 2007 May; 66(5):703-8. PubMed ID: 17388796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons from an unpleasant surprise: a biochemical strategy for the diagnosis of pheochromocytoma.
    Gardet V; Gatta B; Simonnet G; Tabarin A; Chêne G; Ducassou D; Corcuff JB
    J Hypertens; 2001 Jun; 19(6):1029-35. PubMed ID: 11403350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical diagnosis of pheochromocytoma and paraganglioma-induced secondary hypertension through UPLC-MS/MS analysis of plasma catecholamines and their metabolites.
    Zhang W; Li X; Li W; Zhang Y; Cai J; Feng S; Sun Z
    J Clin Hypertens (Greenwich); 2024 Apr; 26(4):416-424. PubMed ID: 38459755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inpatient Measurements of Urine Metanephrines are Indistinguishable from Pheochromocytoma: Retrospective Cohort Study.
    Kline GA; Boyd J; Sadrzadeh HSM; Leung AA
    Am J Med; 2021 Aug; 134(8):1039-1046.e3. PubMed ID: 33864763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of an enzyme immunoassay for plasma-free metanephrines in the diagnosis of catecholamine-secreting tumors.
    Procopiou M; Finney H; Akker SA; Chew SL; Drake WM; Burrin J; Grossman AB
    Eur J Endocrinol; 2009 Jul; 161(1):131-40. PubMed ID: 19383804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.